partially supported by grants from the National Key R&D Program of China (2019YFA0110802);the National Natural Science Foundation of China (81670470 and 81873685);grants from the Shanghai Municipal Commission for Science and Technology (18411953500 and 20140900201);a grant from the Innovation Program of Shanghai Municipal Education Commission (2019-01-07-00-05-E00054);the Fundamental Research Funds for the Central Universities
Genome editing through adeno-associated viral(AAV) vectors is a promising gene therapy strategy for various diseases,especially genetic disorders. However, homologous recombination(HR) efficiency is extremely low in a...
Common neurodegenerative diseases of the central nervous system are characterized by progressive damage to the function of neurons, even leading to the permanent loss of function. Gene therapy via gene replacement or ...
The basal ganglia(BG)act as a cohesive functional unit that regulates motor function,habit formation,and reward/addictive behaviors.However,it is still not well understood how the BG maintains wakefulness and suppress...
Gene therapy as strategy against autoimmune diseases: In the last century, human societies have witnessed remarkable improvements in wellness and life expectancy, thanks to the consolidation of mod- ern science and m...
Gene editing has recently emerged as a promising technology to engineer genetic modifications precisely in the genome to achieve long-term relief from corneal disorders.Recent advances in the molecular biology leading...
Supported by National Natural Science Foundation of China.No.81272687;Zhejiang Provincial Public Welfare Technology Application Research Projects,No.2014C33275;Zhejiang Provincial Natural Science Foundation of China,No.LZ13H160004;the Grant for 521 Talent Project of Zhejiang Sci-Tech University,Hangzhou,China
Human hepatocellular carcinoma(HCC)heavily endangers human heath worldwide.HCC is one of most frequent cancers in China because patients with liver disease,such as chronic hepatitis,have the highest cancer susceptibil...
Adeno-associated virus(AAV) is a small,non-enveloped virus that contains a single-stranded DNA genome. It was the first gene therapy drug approved in the Western world in November 2012 to treat patients with lipoprote...
This study was supported by the Natural Science Foundation of Jiangsu Province(BK2006244);the Key Medical Person Foundation of Jiangsu Province (RC2007051)
Gene therapy is a form of molecular medicine that promises to provide new treatments for a large number of inherited and acquired diseases. One of the biggest stumbling blocks to successful widespread application of g...
This work was supported by the National High Technology Development Program.
Recombinant adeno-associated virus(rAAV) has proven to be a promising gene delivery vector for human gene therapy. However, its application has been limited by difficulty in obtaining enough quantities of high-titer v...
the National High-technology Development Program (Grant No. Z20-05-02).
A novel method for recombinant adeno-associ-ated virus (rAAV) purification on large scale is described. The method involves three steps, including chloroform treatment, PEG/NaCl precipitation and chloroform extraction...